The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)

Recently, the European Medicines Agency (EMA) authorized the introduction and marketing of Thorinane® and Inhixa®, biosimilars of the Low Molecular Weight Heparin (LMWH) enoxaparin. The authorization path is considerably different from the guidelines published by the EMA in 2009, as well as from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Imberti, Davide, Marietta, Marco, Polo Friz, Hernan, Cimminiello, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424282/
https://www.ncbi.nlm.nih.gov/pubmed/28490974
http://dx.doi.org/10.1186/s12959-017-0136-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424282/
https://www.ncbi.nlm.nih.gov/pubmed/28490974
http://dx.doi.org/10.1186/s12959-017-0136-2

Ejemplares similares